Literature DB >> 1741141

The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus.

R Klein1, B E Klein, S E Moss, K L Linton.   

Abstract

The prevalence of diabetic retinopathy was examined in people with newly discovered noninsulin-dependent diabetes mellitus (NIDDM) (n = 50) and in those with previously diagnosed diabetes (n = 395) in a population-based study of people between the ages of 43 and 86 years who lived in Beaver Dam, Wisconsin between 1988 and 1990. Retinopathy was determined from stereoscopic fundus photographs. The prevalence of any retinopathy was 10.2% in those with newly diagnosed NIDDM, none had proliferative retinopathy, and 2.0% had macular edema. These data suggest that asymptomatic people discovered to have NIDDM during epidemiologic studies may not need immediate ophthalmoscopic examination at the time of their diagnosis because they have a relatively low risk of danger of visual loss due to diabetic retinopathy at that time.

Entities:  

Mesh:

Year:  1992        PMID: 1741141     DOI: 10.1016/s0161-6420(92)32011-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  70 in total

1.  The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema.

Authors:  Anjali S Maheshwary; Stephen F Oster; Ritchie M S Yuson; Lingyun Cheng; Francesca Mojana; William R Freeman
Journal:  Am J Ophthalmol       Date:  2010-05-10       Impact factor: 5.258

2.  Associations of selected medications and visual function: the Beaver Dam Eye Study.

Authors:  B E K Klein; R Klein; M D Knudtson; K E Lee; L G Danforth; J O Reinke; A M Adler
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

3.  Interpreting thickness changes in the diabetic macula: the problem of short-term variation in optical coherence tomography-measured macular thickening (an american ophthalmological society thesis).

Authors:  David J Browning
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

4.  Correlates of urinary symptom scores in men.

Authors:  B E Klein; R Klein; K E Lee; R C Bruskewitz
Journal:  Am J Public Health       Date:  1999-11       Impact factor: 9.308

Review 5.  The prevalence of age-related eye diseases and visual impairment in aging: current estimates.

Authors:  Ronald Klein; Barbara E K Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

6.  Association between foveal photoreceptor status and visual acuity after resolution of diabetic macular edema by pars plana vitrectomy.

Authors:  Atsushi Sakamoto; Kazuaki Nishijima; Mihori Kita; Hideyasu Oh; Akitaka Tsujikawa; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-09       Impact factor: 3.117

7.  Parents' attained age and biomarkers of aging in their children.

Authors:  Barbara E K Klein; Michael D Knudtson; Kristine E Lee; Ronald Klein
Journal:  Arch Gerontol Geriatr       Date:  2008-12-13       Impact factor: 3.250

8.  Diabetic Retinopathy: Focus on Minority Populations.

Authors:  Arpine Barsegian; Boleslav Kotlyar; Justin Lee; Moro O Salifu; Samy I McFarlane
Journal:  Int J Clin Endocrinol Metab       Date:  2017-11-11

9.  Risk Factors for Proliferative Diabetic Retinopathy in African Americans with Type 2 Diabetes.

Authors:  Alan Penman; Heather Hancock; Evangelia Papavasileiou; Maurice James; Omolola Idowu; Daniel M Riche; Marlene Fernandez; Stacey Brauner; Sataria O Smith; Suzanne Hoadley; Cole Richardson; Vanessa Vazquez; Cheryl Chi; Christopher Andreoli; Deeba Husain; Ching J Chen; Lucia Sobrin
Journal:  Ophthalmic Epidemiol       Date:  2016-03-07       Impact factor: 1.648

10.  Genome-wide linkage analysis of multiple metabolic factors: evidence of genetic heterogeneity.

Authors:  Ching-Yu Cheng; Kristine E Lee; Priya Duggal; Emily L Moore; Alexander F Wilson; Ronald Klein; Joan E Bailey-Wilson; Barbara E K Klein
Journal:  Obesity (Silver Spring)       Date:  2009-05-14       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.